EA200000204A1 - Pyrrolopyrlonone derivatives as ELASTASIS INHIBITORS NEUTROPHILS - Google Patents
Pyrrolopyrlonone derivatives as ELASTASIS INHIBITORS NEUTROPHILSInfo
- Publication number
- EA200000204A1 EA200000204A1 EA200000204A EA200000204A EA200000204A1 EA 200000204 A1 EA200000204 A1 EA 200000204A1 EA 200000204 A EA200000204 A EA 200000204A EA 200000204 A EA200000204 A EA 200000204A EA 200000204 A1 EA200000204 A1 EA 200000204A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pyrrolopyrlonone
- elastasis
- neutrophils
- inhibitors
- derivatives
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 210000000440 neutrophil Anatomy 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Согласно настоящему изобретению предложены соединения формулы (I), где R, Rи Rявляются такими, как определено в описании. Соединения формулы (I) полезны, в частности, при лечении воспалительных расстройств дыхательных путей.Отчет о международном поиске был опубликован 1999.05.27.According to the present invention, compounds of formula (I) are provided, wherein R, R and R are as defined in the description. The compounds of formula (I) are useful, in particular, in the treatment of inflammatory disorders of the respiratory tract. The international search report was published 1999.05.27.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9719183.7A GB9719183D0 (en) | 1997-09-09 | 1997-09-09 | Compounds |
| GBGB9719189.4A GB9719189D0 (en) | 1997-09-09 | 1997-09-09 | New therapeutic method |
| GBGB9719290.0A GB9719290D0 (en) | 1997-09-10 | 1997-09-10 | Compounds |
| GBGB9803611.4A GB9803611D0 (en) | 1998-02-21 | 1998-02-21 | Compounds |
| PCT/EP1998/005609 WO1999012933A2 (en) | 1997-09-09 | 1998-09-07 | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200000204A1 true EA200000204A1 (en) | 2000-10-30 |
Family
ID=27451698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200000204A EA200000204A1 (en) | 1997-09-09 | 1998-09-07 | Pyrrolopyrlonone derivatives as ELASTASIS INHIBITORS NEUTROPHILS |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1003748A2 (en) |
| JP (1) | JP2001515904A (en) |
| KR (1) | KR20010023766A (en) |
| CN (1) | CN1278820A (en) |
| AP (1) | AP2000001761A0 (en) |
| AR (1) | AR017072A1 (en) |
| AU (1) | AU9741298A (en) |
| BR (1) | BR9812062A (en) |
| CA (1) | CA2303176A1 (en) |
| CO (1) | CO4970719A1 (en) |
| EA (1) | EA200000204A1 (en) |
| EE (1) | EE200000138A (en) |
| HU (1) | HUP0004644A3 (en) |
| ID (1) | ID24452A (en) |
| IL (1) | IL134791A0 (en) |
| IS (1) | IS5391A (en) |
| MA (1) | MA26543A1 (en) |
| NO (1) | NO20001198L (en) |
| NZ (1) | NZ503130A (en) |
| PE (1) | PE107899A1 (en) |
| PL (1) | PL339176A1 (en) |
| SK (1) | SK3192000A3 (en) |
| TR (1) | TR200000907T2 (en) |
| WO (1) | WO1999012933A2 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9905418D0 (en) * | 1999-03-09 | 1999-05-05 | Glaxo Group Ltd | Process |
| AU2005231375A1 (en) | 2004-03-31 | 2005-10-20 | Janssen Pharmaceutica, N.V. | Non-imidazole heterocyclic compounds as histamine H3 receptor modulators |
| DE102004024772A1 (en) * | 2004-05-17 | 2005-12-22 | Grünenthal GmbH | Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides |
| JP4853759B2 (en) * | 2004-05-27 | 2012-01-11 | 日本農薬株式会社 | Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates thereof, agricultural and horticultural agents, and methods of use thereof |
| TWI355380B (en) * | 2004-05-27 | 2012-01-01 | Nihon Nohyaku Co Ltd | Substituted pyrazinecarboxanilide derivatives or s |
| GB2418427A (en) | 2004-09-02 | 2006-03-29 | Univ Cambridge Tech | Ligands for G-protein coupled receptors |
| EP1819681B1 (en) | 2004-11-23 | 2009-08-12 | Warner-Lambert Company LLC | 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia |
| US8198288B2 (en) | 2006-05-04 | 2012-06-12 | Pulmagen Therapeutics (Inflammation) Limited | Tetrahydropyrrolopyrimidinediones and their use in therapy |
| NZ572250A (en) | 2006-05-04 | 2011-10-28 | Pulmagen Therapeutics Inflammation Ltd | Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors |
| US7662967B2 (en) | 2007-08-02 | 2010-02-16 | Cambridge Enterprise Limited | Anti-inflammatory compounds and compositions |
| GB2452696B (en) | 2007-08-02 | 2009-09-23 | Cambridge Entpr Ltd | 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions |
| WO2009060206A1 (en) * | 2007-11-07 | 2009-05-14 | Argenta Discovery Limited | 3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use |
| US20110212181A1 (en) * | 2010-02-26 | 2011-09-01 | The University Of Hong Kong | Compositions and methods for treating chronic respiratory inflammation |
| CN114650819A (en) | 2019-09-17 | 2022-06-21 | 美莱奥生物制药第四有限公司 | Avermectistat for treating graft rejection, bronchiolitis obliterans syndrome and graft-versus-host disease |
| PT4106757T (en) | 2020-04-16 | 2023-11-17 | Mereo Biopharma 5 Inc | METHODS INVOLVING THE NEUTROPHILIC ELASTASE INHIBITOR ALVELESTAT FOR THE TREATMENT OF RESPIRATORY DISEASES MEDIATED BY ALPHA 1 ANTITRIPSIN DEFICIENCY |
| JP2024540952A (en) | 2021-10-20 | 2024-11-06 | メレオ バイオファーマ 4 リミテッド | Neutrophil elastase inhibitors for use in the treatment of fibrosis - Patent Application 20070123333 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9211783D0 (en) * | 1992-06-04 | 1992-07-15 | Ici Plc | Amide derivatives |
| GB9402680D0 (en) * | 1994-02-11 | 1994-04-06 | Zeneca Ltd | Pyrrolidine derivatives |
| EA001437B1 (en) * | 1996-03-28 | 2001-02-26 | Глаксо Груп Лимитед | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
-
1998
- 1998-09-04 PE PE1998000828A patent/PE107899A1/en not_active Application Discontinuation
- 1998-09-07 EA EA200000204A patent/EA200000204A1/en unknown
- 1998-09-07 AR ARP980104458A patent/AR017072A1/en unknown
- 1998-09-07 SK SK319-2000A patent/SK3192000A3/en unknown
- 1998-09-07 CA CA002303176A patent/CA2303176A1/en not_active Abandoned
- 1998-09-07 MA MA25243A patent/MA26543A1/en unknown
- 1998-09-07 JP JP2000510740A patent/JP2001515904A/en active Pending
- 1998-09-07 EP EP98951348A patent/EP1003748A2/en not_active Withdrawn
- 1998-09-07 BR BR9812062-0A patent/BR9812062A/en not_active Application Discontinuation
- 1998-09-07 PL PL98339176A patent/PL339176A1/en not_active Application Discontinuation
- 1998-09-07 HU HU0004644A patent/HUP0004644A3/en unknown
- 1998-09-07 TR TR2000/00907T patent/TR200000907T2/en unknown
- 1998-09-07 AP APAP/P/2000/001761A patent/AP2000001761A0/en unknown
- 1998-09-07 NZ NZ503130A patent/NZ503130A/en unknown
- 1998-09-07 AU AU97412/98A patent/AU9741298A/en not_active Abandoned
- 1998-09-07 IL IL13479198A patent/IL134791A0/en unknown
- 1998-09-07 WO PCT/EP1998/005609 patent/WO1999012933A2/en not_active Ceased
- 1998-09-07 EE EEP200000138A patent/EE200000138A/en unknown
- 1998-09-07 KR KR1020007002422A patent/KR20010023766A/en not_active Withdrawn
- 1998-09-07 ID IDW20000445A patent/ID24452A/en unknown
- 1998-09-07 CN CN98810954A patent/CN1278820A/en active Pending
- 1998-09-08 CO CO98051488A patent/CO4970719A1/en unknown
-
2000
- 2000-02-29 IS IS5391A patent/IS5391A/en unknown
- 2000-03-08 NO NO20001198A patent/NO20001198L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ID24452A (en) | 2000-07-20 |
| CN1278820A (en) | 2001-01-03 |
| CO4970719A1 (en) | 2000-11-07 |
| WO1999012933A2 (en) | 1999-03-18 |
| PE107899A1 (en) | 1999-11-17 |
| TR200000907T2 (en) | 2000-11-21 |
| AR017072A1 (en) | 2001-08-22 |
| MA26543A1 (en) | 2004-12-20 |
| NO20001198D0 (en) | 2000-03-08 |
| IL134791A0 (en) | 2001-04-30 |
| CA2303176A1 (en) | 1999-03-18 |
| EP1003748A2 (en) | 2000-05-31 |
| JP2001515904A (en) | 2001-09-25 |
| PL339176A1 (en) | 2000-12-04 |
| EE200000138A (en) | 2001-02-15 |
| SK3192000A3 (en) | 2001-03-12 |
| WO1999012933A3 (en) | 1999-05-27 |
| HUP0004644A2 (en) | 2001-09-28 |
| NO20001198L (en) | 2000-05-08 |
| BR9812062A (en) | 2000-09-26 |
| IS5391A (en) | 2000-02-29 |
| NZ503130A (en) | 2001-08-31 |
| HUP0004644A3 (en) | 2002-01-28 |
| AP2000001761A0 (en) | 2000-03-31 |
| AU9741298A (en) | 1999-03-29 |
| KR20010023766A (en) | 2001-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199900853A1 (en) | SUBSTITUTED DERIVATIVES OF BENZOPIRANE FOR THE TREATMENT OF INFLAMMATORY PROCESSES | |
| FI970246A7 (en) | Dihydrobenzofurans | |
| EA200100412A1 (en) | SUBSTITUTED 3-CYANOHINOLINES AS PROTEINTHYROSINKINASE INHIBITORS | |
| ATE269312T1 (en) | N-(AMIDINOPHENYL)-N'-(NOUN)-3H-2,4-BENZODIAZEPINE-3-ONE DERIVATIVES AS FACTOR XA INHIBITORS | |
| EA200100203A1 (en) | DERIVATIVES 4,4-BIARILPIPERIDIN WITH ACTIVITY WITH RESPECT TO OPIOID RECEPTORS | |
| BR9900177A (en) | Metalloprotease inhibitors. | |
| EA200400648A1 (en) | N, N'-SUBSTITUTED DERIVATIVES 1,3-DIAMINO-2-HYDROXYPROPANE | |
| AP2002002637A0 (en) | Novel piperazine | |
| TR200000059T2 (en) | Pyridine derivatives | |
| PT1140944E (en) | EPOTILONE DERIVATIVES AND THEIR USE AS ANTITUMATIC AGENTS | |
| YU44398A (en) | Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors | |
| BR0114045A (en) | Polyarylcarboxamides useful as lipid lowering agents | |
| TR200200579T2 (en) | Amino-thyrazolpyridine derivatives. | |
| EA200000204A1 (en) | Pyrrolopyrlonone derivatives as ELASTASIS INHIBITORS NEUTROPHILS | |
| PT896533E (en) | PENTAFLUOROBENZENOSULFONAMIDAS AND ANALOGOS | |
| PT1123276E (en) | N- (2-ARYL-PROPIONYL) -SULFONAMIDES AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM | |
| EA200300836A1 (en) | DERIVATIVES OF PHTHALASINON-PIPERIDINE AS PDE4 INHIBITORS | |
| IT1285770B1 (en) | CORTICOID COMPOUNDS | |
| DK0672659T3 (en) | Antithrombotic agents | |
| EA200100516A1 (en) | DERIVATIVES 3,3-BIARILPIPERIDINA AND 2,2-BIARYLMORPHOLINE | |
| ATE303384T1 (en) | 1-BIARYL-1,8-NAPHTHYRIDINE-4-ONE AS PHOSPHODIESETERASE INHIBITORS | |
| EA200000741A1 (en) | NEW DIHYDROXYGEXANE ACID DERIVATIVES | |
| SE9801494D0 (en) | Novel use | |
| MY128261A (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
| TR200201128T2 (en) | Tetrahydrothiopyraniphalazinone derivatives as PDE4 inhibitors. |